Concurrent transposon engineering and CRISPR/Cas9 genome editing of primary CLL-1 chimeric antigen receptor–natural killer cells

Cytotherapy(2022)

引用 5|浏览19
暂无评分
摘要
This report contributes a promising application of transposon engineering to donor-derived NK cells and emphasizes the importance of feeder mediated NK cell activation and expansion to current protocols.
更多
查看译文
关键词
CAR-NK cells,CRISPR/Cas9,DNA transposon,Genome editing
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要